lymphomanewstoday.com/

h1s:
- Updates
- A Farewell Note to My Beloved Readers
- A Light-giver Shares a Lesson in Emotional Honesty
- Embarking on a New Chapter While Cherishing the Value of Community
- Shedding My Sickness While Acknowledging Its Eternal Impact
- Sometimes Everything Works Out All Right
- Let’s Not Forget the Superheroes
- Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
- Can a Break From Routine Induce Healing?
- Reflections on My ‘Re-birthday’ and the Past Year of Recovery
- This Year Has Taught Me Gratitude
- Total Happiness Is Unobtainable, and That’s OK
- As I Befriend My Fear of Relapse, Fear Loses Its Power
- How to Embrace Pain and Let It Transform You
- My Quarantine Glow-up: Getting Fit After Cancer
- Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe
- FDA Decision on Liso-cel, CAR T-cell Therapy for Large B-cell Lymphoma, Due in November
- Cirmtuzumab-Imbruvica Yields ‘Encouraging’ Response Rates Against Mantle Cell Lymphoma, Ongoing Trial Shows
- Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak
- Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say
- Despite the Struggle, I Have Found Solace in Solitude
- 1st Patient Treated in Phase 1 Trial of ATG-019 for Lymphoma, Solid Tumors
- Keytruda Prolongs Life Without Disease Worsening in Classical Hodgkin’s Lymphoma, Interim Data Confirm
- Finding Beauty in the Brokenness
- ME-401 Put on FDA’s Fast Track for Previously Treated Follicular Lymphoma
- Zevalin Improves Survival of Non-Hodgkin’s Lymphoma Patients in Real-world Setting, Study Finds
- As a Member of the Cancer Club, Coronavirus Is Not Fun
- FDA Grants Orphan Drug Status to Umbralisib for Follicular Lymphoma
- First Patient Treated in MB-106 CAR T-cell Trial Now Cancer Free, Mustang Says
- CLR 131 Shows Anti-tumor Activity, Safety in Difficult-to-treat B-cell Lymphoma Trial
- Tafasitamab Plus Revlimid Granted FDA Priority Review for Relapsed or Refractory DLBCL
- The Paradox of Healing
- Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare
- Tipifarnib Granted FDA Fast Track Designation for T-cell Lymphomas
- Recent Posts
- Featured Posts
- CHMP Recommends Approval of Generic Carmustine for Lymphoma, Brain Tumors
- Disclaimer:
h2s:
- Subscribe to our mailing list
h3s:
title: Lymphoma News Today Home | Lymphoma News Today
emails:
gliner:
- city: ['Pensacola']
- street: ['3 W Garden St']
- postcode: ['32502']
robots: index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1
keywords: None
og_title: Lymphoma News Today Home | Lymphoma News Today
addresses:
- 3 W Garden St Suite 700 Pensacola, FL 32502
canonical: https://lymphomanewstoday.com/
text_size: 20979
rta_rating: None
h1_analysis: multiple
h2_analysis: 1 found
og_site_name: Lymphoma News Today
url_analysis:
phone_numbers:
- +1-800-936-1363
summary_issues:
- h1: multiple
- Meta description tag is missing or empty.
title_analysis: ok
meta_description: None
canonical_analysis: self-referencing
responsive_analysis:
- score: 15
- messages_bad: []
- messages_good: ['Recommended viewport tag found.', 'Potential responsive CSS (@media, max/min-width) detected in HTML source.']
searchengine_analysis:
- score: 20
- messages_bad: ['Meta description tag is missing or empty.']
- messages_good: ['H1 tag(s) found.', 'Site uses HTTPS.', 'Robots meta tag found: index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1']
meta_description_analysis: missing

Lymphoma News Today Home | Lymphoma News Today

Contact Information

More Details